Genesis IBRC Market Cap ($42.92M USD)
Genesis IBRC Market Cap ($42.92M USD). As of April 20, 2026, Genesis IBRC (GENESIS) market capitalisation is ₹386.27 Cr ($42.92M), with 4.53 Cr shares outstanding at a current price of ₹85.36 on BSE, ranking 2064 out of 5368 companies by market cap in our screener. Genesis IBRC operates in the Healthcare sector and is classified as a Small Cap stock. For live price, earnings and the complete company profile, see Genesis IBRC screener.
Market Cap History of Genesis IBRC (Last 10 Years)
GENESIS market capitalisation from year-end BSE closing prices over the last 10 years. Compare with GENESIS DCF valuation to assess whether the stock is under or overvalued.
End of Year Market Cap History — Genesis IBRC
GENESIS year-end market cap in INR and USD with closing share price and annual change — BSE closing prices. Review Genesis IBRC price earnings to evaluate earnings-based valuation against sector peers.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹386.27 Cr
$42.92M USD
|
₹85.36 | BSE | +0.07% |
| 2025 |
₹386.00 Cr
$42.89M USD
|
₹85.30 | BSE | +388.27% |
| 2024 |
₹79.06 Cr
$8.78M USD
|
₹17.47 | BSE | +79.55% |
| 2023 |
₹44.03 Cr
$4.89M USD
|
₹9.73 | BSE | -9.07% |
| 2022 |
₹48.42 Cr
$5.38M USD
|
₹10.70 | BSE | +35.44% |
| 2021 |
₹35.75 Cr
$3.97M USD
|
₹7.90 | BSE | +5.90% |
| 2020 |
₹33.76 Cr
$3.75M USD
|
₹7.46 | BSE | -3.74% |
| 2019 |
₹35.07 Cr
$3.90M USD
|
₹7.75 | BSE | +33.62% |
| 2018 |
₹26.25 Cr
$2.92M USD
|
₹5.80 | BSE | +20.83% |
| 2017 |
₹21.72 Cr
$2.41M USD
|
₹4.80 | BSE | -66.08% |
| 2016 |
₹64.03 Cr
$7.11M USD
|
₹14.15 | BSE | -13.03% |
| 2015 |
₹73.62 Cr
$8.18M USD
|
₹16.27 | BSE | +168.93% |
| 2014 |
₹27.38 Cr
$3.04M USD
|
₹6.05 | BSE | -9.16% |
| 2013 |
₹30.14 Cr
$3.35M USD
|
₹6.66 | BSE | +215.64% |
| 2012 |
₹9.55 Cr
$1.06M USD
|
₹2.11 | BSE | - |